Abstract:Background: Proline-rich transmembrane protein 2 (PRRT2) plays an important role in the central nervous system and mutations in the gene are implicated in a variety of neurological disorders. This study aimed to summarize the clinical characteristics and gene expression analysis of neurological diseases related to the PRRT2 gene and explore the clinical characteristics, therapeutic effects, and possible pathogenic mechanisms of related diseases. Methods: We enrolled 10 children with PRRT2 mutation-related neurological diseases who visited the Children's Hospital affiliated with the Shanghai Jiaotong University School of Medicine/Shanghai Children's Hospital between May 2017 and February 2022. Video electroencephalography (VEEG), cranial imaging, treatment regimens, gene results, and gene expression were analyzed. Genetic testing involved targeted sequencing or whole-exome genome sequencing (WES). We further analyzed the expression and mutation conservation of PRRT2 and synaptosome-associated protein 25 (SNAP25) in blood samples using quantitative polymerase chain reaction (qPCR) and predicted the protein structure. Summary analysis of the reported gene maps and domains was also performed. Results: Ten children with PRRT2 gene mutations were analyzed, and 4 mutations were identified, consisting of 2 new (c.518A > C, p.Glu173 Ala; c.879 + 112G > A, p.?) and two known (c. 649 dup, p. Arg217Profs * 8; c. 649 del, p. Arg217Glufs * 12) mutations. Among these mutations, one was de novo (P6), and three could not be determined because one parent refused genetic testing. The clinical phenotypes were paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), epilepsy, infantile spasms, and intellectual disability. The qPCR results showed that PRRT2 gene expression levels were significantly lower in children and parent carriers than the control group. The SNAP25 gene expression level of affected children was significantly lower ( P ≤ 0.001) than that of the control group. The mutation sites reported in this study are highly conserved in different species. Among the various drugs used, oxcarbazepine and sodium valproate were the most effective. All 10 children had a good disease prognosis, and 8 were completely controlled with no recurrence, whereas 2 had less severe and fewer seizures. Conclusion: Mutation of PRRT2 led to a significant decrease in its protein expression level and that of SNAP25, suggesting that the mutant protein may lead to the loss of its function and that of related proteins. This mutation site is highly conserved in most species, and there was no significant correlation between specific PRRT2 genotypes and clinical phenotypes. Asymptomatic carriers also have decreased gene expression levels, suggesting that more factors are involved.

Novel Mutations of the POLR3A Gene Caused POLR3-related Leukodystrophy in a Chinese Family: a Case Report

A Novel Variant of the POLR3A Gene in a Chinese Patient with POLR3-related Leukodystrophy

POLR3-related leukodystrophy caused by biallelic POLR3A and 1C pathogenic variants: a single-center experience

Clinical phenotype and genetic function analysis of a family with hypomyelinating leukodystrophy-7 caused by POLR3A mutation

New Clinical Characteristics and Novel Pathogenic Variants of Patients with Hereditary Leukodystrophies

Compound heterozygous mutations in POLR3A gene cause global developmental delay with epilepsy and striatal degeneration

Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III

Craniofacial features of POLR3-related leukodystrophy caused by biallelic variants in POLR3A, POLR3B and POLR1C

Case report: Biallelic variants in POLR3B gene lead to 4H leukodystrophy from the study of brother and sister

A de novo variant of POLR3B causes demyelinating Charcot-Marie-Tooth disease in a Chinese patient: a case report

Case Report: A Homozygous Mutation (p.Y62X) of Phospholipase D3 May Lead to a New Leukoencephalopathy Syndrome

Coffin-Lowry Syndrome Induced by RPS6KA3 Gene Variation in China: A Case Report in Twins

POLR3B de novo variants are a rare cause of infantile myoclonic epilepsy

Clinical characteristics and genetics of ten Chinese children with PRRT2-associated neurological diseases

A Novel Compound Heterozygous Mutation in AARS2 Gene (c.965 G > A, P.r322h; C.334 G > C, P.g112r) Identified in a Chinese Patient with Leukodystrophy Involved in Brain and Spinal Cord

Three novel mutations in Chinese patients with CSF1R-related leukoencephalopathy

Molecular basis of neurodegeneration in a mouse model of Polr3 -related disease

[Clinical and Genetic Analysis of a Family with Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation].

Clinical, genetic, and molecular characteristics in a central‐southern Chinese cohort of genetic leukodystrophies

Novel variants in AP4B1 cause spastic tetraplegia, moderate psychomotor development delay and febrile seizures in a Chinese patient: a case report

Alanyl-transfer ribonucleic acid synthetase 2 gene mutation producing leukodystrophy: a case report